Cadwalader allows sharing content.
Email to a friend or colleague:
From
To
Subject
Email The Knowledge Group has developed a panel of key thought Leaders and practitioners to help companies understand the Hart-Scott-Rodino (HSR) rules for patent acquisitions, including the new rules of the Federal Trade Commission (FTC) for exclusive pharmaceutical patent licenses. The program will cover the most significant topics involved along with a Q&A panel to whom the attendees' questions will be addressed. https://www.cadwalader.com/resources/events/patent-acquisitions-when-are-they-hsr-reportable